Galen gets three year contract to chew on
Northern Ireland pharmaceutical company Galen Holdings said today it has won three-year exclusivity for its Ovcon product.
Ovcon is marketed in the US by Galen's subsidiary Warner Chilcott. The new product is in the form of chewable tablets.





